The Centers for Medicare & Medicaid Services last week approved Section 1115 waivers allowing Minnesota and Nebraska to implement demonstration projects to increase access and treatment for Medicaid beneficiaries with opioid and other substance use disorders. Both states will receive Medicaid matching funds for treatment in facilities that meet the definition of an institution for mental diseases, which include hospitals and other residential treatment facilities with more than 16 beds that are primarily engaged in diagnosis, treatment or care of persons with mental diseases. CMS outlined additional waiver opportunities last November for states to treat SUDs and mental illness.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services yesterday released a fact sheet for state and local governments seeking Medicare, Medicaid or Children’s…
Headline
State Medicaid programs are reporting an uptick in enrollment compared with their fiscal year 2020 projections, due in part to the COVID-19 pandemic. The…
Headline
The National Academies of Sciences Engineering, and Medicine yesterday released recommendations for improving outcomes and metrics associated with four grant…
Headline
The Substance Abuse and Mental Health Services Administration Friday awarded $450 million in grants, including $250 million in emergency COVID-19 funding, to…
Headline
The Centers for Medicare & Medicaid Services recently announced a six-month delay in implementation of its Innovation Center Maternal Opioid Misuse (MOM)…
Headline
The Centers for Medicare & Medicaid Services yesterday approved a state of Washington-developed emergency demonstration project to adjust its Medicaid…